Hi Milcom, I can see how it is easy to create doubt and confusion here. One needs to take into account how far down the track of the 12 to 18-month life expectancy our patients were when they commenced our treatment. Were they first diagnosed 14 mths ago and are now living up to 20 mths longer and counting than those on SOC?
When you put the figures into context and compare the data side by side with other treatments, I don't think we can doubt the efficacy and safety of what we have happening here.
- Forums
- ASX - By Stock
- CHM
- Chimeric: Media Thread
Chimeric: Media Thread, page-597
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.951M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 0.9¢ | $31.02K | 3.091M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 452554 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 350000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 452554 | 0.010 |
26 | 6257135 | 0.009 |
18 | 6189781 | 0.008 |
15 | 5983427 | 0.007 |
5 | 1744766 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 350000 | 1 |
0.012 | 1766613 | 7 |
0.013 | 153846 | 1 |
0.014 | 655016 | 2 |
0.015 | 579596 | 1 |
Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |